Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients

January 16, 2014

University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.

University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.

Related Content:

InterviewsCOPDRetail
Investigative Report Leads to Changes in Illinois
Survey Finds Consumers in Pain Over High Prescription Prices, In Need of Better Tools
Note Proper Use of Antihistamines During Spring Allergy Season